Department of Veterans Affairs

VA Opens Door to Psychedelic Research for PTSD and Depression: A Revolutionary Approach Could Reshape Veterans’ Mental Health Care

The DepartsubsAffairs (VA) is taking a bold step into uncharted territory, seeking proposals from its network of researchers to study the use of psychedelic compounds in treating posttraumatic stress disorder …

VA Opens Door to Psychedelic Research for PTSD and Depression: A Revolutionary Approach Could Reshape Veterans’ Mental Health Care Read More

NRx Pharmaceuticals

NRx Pharmaceuticals Announces Signing of a Development Agreement for the Manufacture of Ketamine to Treat Suicidality and Depression

RADNOR, PA — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) recently announced the signing of a development contract to manufacture a presentation of ketamine suitable for intravenous administration under current FDA manufacturing …

NRx Pharmaceuticals Announces Signing of a Development Agreement for the Manufacture of Ketamine to Treat Suicidality and Depression Read More